Books+ Search Results
Follow-on biologics hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007
Title
Follow-on biologics [electronic resource] : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining Food and Drug Administration follow-on biologics, generally referred to as a biotechnology-derived protein drug (or biologic) that is comparable to a novel, previously approved biologic and that is approved with less supporting data than the innovator biologic, March 8, 2007.
Published
Washington : U.S. G.P.O., 2008.
Physical Description
1 electronic text (iv, 78 p.) : HTML, digital, PDF file.
Notes
Title from title screen (viewed on Nov. 17, 2008).
Other formats
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Follow-on biologics
Format
Books / Online
Language
English
Added to Catalog
December 15, 2008
Series
S. hrg. ; 110-375
System details note
Mode of access: Internet from the GPO Access web site. Addresses as of 11/17/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.wais (text version); http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110%5Fsenate%5Fhearings&docid=f:34053.pdf (PDF version) ; current access is available via PURLs.
Bibliography
Includes bibliographical references.
Subjects
Bookmark As
Citation
